AAAAAA
Results:
1-9
|
Results: 9
Authors:
Pernerstorfer-Schoen, H
Jilma, B
Perschler, A
Wichlas, S
Schindler, K
Schindl, A
Rieger, A
Wagner, OF
Quehenberger, P
Citation: H. Pernerstorfer-schoen et al., Sex differences in HAART-associated dyslipidaemia, AIDS, 15(6), 2001, pp. 725-734
Authors:
Fodinger, M
Wagner, OF
Horl, WH
Sunder-Plassmann, G
Citation: M. Fodinger et al., Recent insights into the molecular genetics of the homocysteine metabolism, KIDNEY INT, 59, 2001, pp. S238-S242
Authors:
Jilma, B
Blann, AD
Stohlawetz, P
Eichler, HG
Kautzky-Willer, A
Wagner, OF
Citation: B. Jilma et al., Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men, J LA CL MED, 135(3), 2000, pp. 270-274
Authors:
Jilma, B
Dallinger, S
Hergovich, N
Eichler, HG
Richter, V
Wagner, OF
Citation: B. Jilma et al., Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules, J CLIN END, 85(5), 2000, pp. 1748-1751
Authors:
Jilma, B
Blann, A
Pernerstorfer, T
Stohlawetz, P
Eichler, HG
Vondrovec, B
Amiral, J
Richter, V
Wagner, OF
Citation: B. Jilma et al., Regulation of adhesion molecules during human endotoxemia - No acute effects of aspirin, AM J R CRIT, 159(3), 1999, pp. 857-863
Authors:
Gasic, S
Wagner, OF
Fasching, P
Ludwig, C
Veitl, M
Kapiotis, S
Jilma, B
Citation: S. Gasic et al., Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria, AM J HYPERT, 12(2), 1999, pp. 217-222
Authors:
Fodinger, M
Sunder-Plassmann, G
Wagner, OF
Citation: M. Fodinger et al., Trends in molecular diagnostics, WIEN KLIN W, 111(8), 1999, pp. 315-319
Authors:
Jilma, B
Hergovich, N
Stohlawetz, P
Eichler, HG
Bauer, P
Wagner, OF
Citation: B. Jilma et al., Circadian variation of granulocyte colony stimulating factor levels in man, BR J HAEM, 106(2), 1999, pp. 368-370
Authors:
Locker, GJ
Kapiotis, S
Veitl, M
Mader, RM
Stoiser, B
Kofler, J
Sieder, AE
Rainer, H
Steger, GG
Mannhalter, C
Wagner, OF
Citation: Gj. Locker et al., Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders, BR J HAEM, 105(4), 1999, pp. 912-919
Risultati:
1-9
|